Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea · Delayed Price · Currency is KRW 1,940.00
0.00 (0.00%)
At close: Jul 15, 2025, 3:30 PM KST
KOSDAQ:175250 Revenue
Icure Pharmaceutical Incorporation had revenue of 22.13B KRW in the quarter ending March 31, 2025, with 38.86% growth. This brings the company's revenue in the last twelve months to 75.40B, up 32.03% year-over-year. In the year 2024, Icure Pharmaceutical Incorporation had annual revenue of 69.21B with 21.83% growth.
Revenue (ttm)
75.40B
Revenue Growth
+32.03%
P/S Ratio
0.96
Revenue / Employee
359.05M
Employees
210
Market Cap
72.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69.21B | 12.40B | 21.83% |
| Dec 31, 2023 | 56.81B | -2.56B | -4.31% |
| Dec 31, 2022 | 59.37B | -4.92B | -7.65% |
| Dec 31, 2021 | 64.28B | -25.86B | -28.69% |
| Dec 31, 2020 | 90.14B | 29.22B | 47.97% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |